WallStreetZenWallStreetZen

NASDAQ: ENTX
Entera Bio Ltd Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

ENTX past revenue growth

How has ENTX's revenue growth performed historically?
Company
-100%
Industry
145.73%
Market
17.2%
ENTX's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
ENTX's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
ENTX's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

ENTX earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$8.9M
Current Profit Margin
0%

ENTX Return on Equity

Current Company
-101.8%
Current Industry
-63.5%
Current Market
188%
ENTX's Return on Equity (-101.8%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when ENTX announces earnings.

ENTX Return on Assets

Current Company
-83.9%
Current Industry
2.9%
ENTX is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

ENTX Return on Capital Employed

Current Company
-83.01%
Current Industry
19.5%
ENTX has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ENTX vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
ENTX$0.00-$8.80M-$8.89M-100.00%N/A
LABP$0.00-$21.94M-$21.94MN/AN/A
ANEB$0.00-$10.46M-$10.49MN/AN/A
LVTX$7.36M-$47.16M-$45.62M+86.44%N/A
CRVS$0.00-$26.88M-$27.03MN/AN/A
View Top Biotech Stocks

ENTX earnings dates

Next earnings date
May 3, 2024

Entera Bio Earnings & Revenue FAQ

What were ENTX's earnings last quarter?

On Invalid Date, Entera Bio (NASDAQ: ENTX) reported Q4 2023 earnings per share (EPS) of -$0.07, up 30% year over year. Total Entera Bio earnings for the quarter were -$2.00 million. In the same quarter last year, Entera Bio's earnings per share (EPS) was -$0.10.

If you're new to stock investing, here's how to buy Entera Bio stock.

What was ENTX's earnings growth in the past year?

As of Q2 2024, Entera Bio's earnings has grown year over year. Entera Bio's earnings in the past year totalled -$8.89 million.

What is ENTX's earnings date?

Entera Bio's earnings date is Invalid Date. Add ENTX to your watchlist to be reminded of ENTX's next earnings announcement.

What was ENTX's revenue last quarter?

On Invalid Date, Entera Bio (NASDAQ: ENTX) reported Q4 2023 revenue of $0.00 up 100% year over year. In the same quarter last year, Entera Bio's revenue was $14.00 thousand.

What was ENTX's revenue growth in the past year?

As of Q2 2024, Entera Bio's revenue has grown -100% year over year. This is 245.73 percentage points lower than the US Biotechnology industry revenue growth rate of 145.73%. Entera Bio's revenue in the past year totalled $0.00.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.